Skip to main content

Vivolo-Kantor Alana

Description

Recent reporting using data from CDC's National Syndromic Surveillance Program indicates that rates of emergency department (ED) visits involving suspected opioid overdoses increased by 70% in the Midwest from the third quarter (Q3) 2016 (July-September) to the Q3 2017. Large increases in the use and distribution of illicitly-manufactured fentanyl (IMF) and fentanyl analogs, are a key factor driving increased opioid overdose rates in the Midwest and east of the Mississippi River. Fentanyl is a synthetic opioid 50-“100 times more potent than morphine. A better understanding of the distribution of changes in opioid overdose rate from Q3 2016 to Q3 2017 within states needed to inform response and prevention efforts.

Objective: This presentation will provide insight into how the extensive spread of illicitly-manufactured fentanyl impacted opioid overdose rates throughout the Midwest and neighboring states.

Submitted by elamb on
Description

State and local jurisdictions have been exploring the use of SyS data to monitor suspected drug overdose outbreaks in their communities. With the increasing awareness and use of SyS systems, staff from the Centers for Disease Control and Prevention (CDC) worked to develop several queries that jurisdictions could use to better capture suspected drug overdose visits. In 2017, CDC released their first two queries on heroin overdose and opioid overdose, followed in 2018 by stimulant and all drug overdose queries. Over time, and with the assistance from the SyS community and the CDC-funded Enhanced State Opioid Overdose Surveillance (ESOOS) state health departments, CDC has revised the queries to address suggestions from jurisdictions. However, it'™s not clear how often and in what way the syndrome definitions are updated over time. This is particularly true as new drugs emerge and the names of those drugs are integrated into syndrome definitions (e.g., recent Spice and œK2 synthetic cannabinoid outbreaks).

Objective: To discuss the process for developing and revising suspected drug overdose queries in syndromic surveillance (SyS) systems.

Submitted by elamb on
Description

Suicide is a growing public health problem in the United States. From 2001 to 2016, ED visit rates for nonfatal self-harm, a common risk factor for suicide, increased 42%. To improve public health surveillance of suicide-related problems, including SI and SA, the Data and Surveillance Task Force within the National Action Alliance for Suicide Prevention recommended the use of real-time data from hospital ED visits. The collection and use of real-time ED visit data on SI and SA could support a more targeted and timely public health response to prevent suicide. Therefore, this investigation aimed to monitor ED visits for SI or SA and to identify temporal, demographic, and geographic patterns using data from CDC's National Syndromic Surveillance Program (NSSP).

Objective: To describe epidemiological characteristics of emergency department (ED) visits related to suicidal ideation (SI) or suicidal attempt (SA) using syndromic surveillance data.

Submitted by elamb on
Description

Timely and accurate measurement of overdose morbidity using emergency department (ED) data is necessary to inform an effective public health response given the dynamic nature of opioid overdose epidemic in the United States. However, from jurisdiction to jurisdiction, differing sources and types of ED data vary in their quality and comprehensiveness. Many jurisdictions collect timely emergency department data through syndromic surveillance (SyS) systems, while others may have access to more complete, but slower emergency department discharge datasets. State and local epidemiologists must make decisions regarding which datasets to use and how to best operationalize, interpret, and present overdose morbidity using ED data. These choices may affect the number, timeliness, and accuracy of the cases identified.

Objective: Epidemiologists will understand the differences between syndromic and discharge emergency department data sources, the strengths and limitations of each data source, and how each of these different emergency department data sources can be best applied to inform a public health response to the opioid overdose epidemic.

Submitted by elamb on

These slides were presented at the Enhanced State Opioid Overdose Surveillance (ESOOS) Program Overview Partner meeting, led by CDC and organized by ASTHO in March of 2019. 

Presenters

Puja Seth, PhD – Lead, Epidemiology and Surveillance

Alana Vivolo-Kantor, PhD – Morbidity Lead

Christine L. Mattson, PhD – Mortality Lead

Objectives

Submitted by uysz on

THE KNOWLEDGE REPOSITORY HAS BEEN UPDATED TO INCLUDE CDC ALL DRUG V2 - THE UPDATED SYNDROME DEFINITION CAN BE FOUND HERE.

Submitted by Anonymous on

THE KNOWLEDGE REPOSITORY HAS BEEN UPDATED TO INCLUDE CDC OPIOID V3 - THE UPDATED SYNDROME DEFINITION CAN BE FOUND HERE.

Submitted by Anonymous on

THE KNOWLEDGE REPOSITORY HAS BEEN UPDATED TO INCLUDE CDC HEROIN OVERDOSE V4 - THE UPDATED SYNDROME DEFINITION CAN BE FOUND HERE.

Submitted by Anonymous on

THE KNOWLEDGE REPOSITORY HAS BEEN UPDATED TO INCLUDE CDC STIMULANT OVERDOSE V3 - THE UPDATED SYNDROME DEFINITION CAN BE FOUND HERE.

Submitted by Anonymous on

THE KNOWLEDGE REPOSITORY HAS BEEN UPDATED TO INCLUDE CDC STIMULANT OVERDOSE V3 - THE UPDATED SYNDROME DEFINITION CAN BE FOUND HERE.

Submitted by Anonymous on